Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Maura

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Blood Cancer Discovery|March 5, 2024
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple MyelomaIrene M Ghobrial, Nicole Gormley, Shaji K Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple MyelomaFrancesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Cancer Research|June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple MyelomaRafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Research Square|May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaRafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Scientific Reports|September 12, 2018
An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signaturesGrace Collord, Patrick Tarpey, Natalja Kurbatova, et al.
JAMA Oncology|April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical TrialOla Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Nature Communications|January 21, 2021
Author Correction: Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Nature Communications|July 19, 2020
Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor ConditionsFrancesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Cell|April 17, 2018
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx RenalThomas J Mitchell, Samra Turajlic, Andrew Rowan, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Blood Cancer Discovery|March 5, 2024
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple MyelomaIrene M Ghobrial, Nicole Gormley, Shaji K Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple MyelomaFrancesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Cancer Research|June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple MyelomaRafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Research Square|May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaRafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Scientific Reports|September 12, 2018
An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signaturesGrace Collord, Patrick Tarpey, Natalja Kurbatova, et al.
JAMA Oncology|April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical TrialOla Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
Nature Communications|January 21, 2021
Author Correction: Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Nature Communications|July 19, 2020
Accelerated single cell seeding in relapsed multiple myelomaHeather J Landau, Venkata Yellapantula, Benjamin T Diamond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor ConditionsFrancesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Cell|April 17, 2018
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx RenalThomas J Mitchell, Samra Turajlic, Andrew Rowan, et al.
Pageof 15